Biocon Ltd. — Regulatory Filings 2020

Jun 9, 2020

==> picture [132 x 52] intentionally omitted <==

Biocon Limited 20th KM, Hosur Road Electronic City Bangalore 560 100, India T 91 80 2808 2808 F 91 80 2852 3423 CIN : L24234KA1978PLC003417

www.biocon.com

Date of submission: June 9, 2020

To	To
The Secretary	The Secretary
BSE Limited	National Stock Exchange of India Limited
Department of Corporate Services	Corporate Communication Department
Phiroze Jeejeebhoy Towers,	Exchange Plaza, Bandra Kurla Complex
Dalal Street,Mumbai – 400 001	Mumbai – 400 050
Scrip Code - 532523	Scrip Symbol- BIOCON

Dear Sir/Madam,

Sub: Meetings conducted with Institutional Investors/Research Analysts.

Ref: Intimation under Regulation 30 (6) of SEBI Listing Obligations and Disclosure Requirements (LODR) Regulations, 2015.

Pursuant to Regulation 30 (6) of the SEBI LODR Regulations, 2015, we hereby inform you that the following meetings were conducted with Institutional Investor / Research Analysts:

Date	Name	Type of meeting	Location
	Ashmore Investment Management
	Doric Capital
	Ellerston Capital
	FidelityManagement & Research	1x1 & Group
June 9, 2020	ICICI Prudential Asset Management	Teleconference	Bangalore
	Ishana Capital	based Meetings
	Quantum Asset Management
	Morgan StanleyIndia CompanyPvt. Ltd.
	Singapore InvestCorp (India)Pvt. Ltd.

We request you to kindly take above intimation on record.

Thanking You,

Yours faithfully,

For Biocon Limited

==> picture [97 x 37] intentionally omitted <==

==> picture [77 x 81] intentionally omitted <==

---

Mayank Verma Company Secretary and Compliance Officer